Question 1

Who is Ann Hanham?

Accepted Answer

Ann Hanham serves as Executive at BIOMIMETIC THERAPEUTICS, INC. (BMTI). They have executed 49 insider transactions totaling $5.4M over their tenure at the company.

Question 2

What is Ann Hanham's role at BIOMIMETIC THERAPEUTICS, INC.?

Accepted Answer

Ann Hanham holds the position of Executive at BIOMIMETIC THERAPEUTICS, INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.

Question 3

Is Ann Hanham buying or selling BMTI stock?

Accepted Answer

Ann Hanham has shown a selling trading pattern, with $15.4K in total purchases and $5.4M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.

Question 4

What are Ann Hanham's largest insider transactions?

Accepted Answer

The largest transaction by Ann Hanham was on Feb 4, 2011, when they purchased $2.8M worth of ECYT shares. This transaction involved 461,608 shares at $6.00 per share.

Question 5

What is Ann Hanham's trading accuracy?

Accepted Answer

Ann Hanham has a Personal Accuracy Score of 69/100, which measures the historical performance of their insider transactions. This score is calculated based on the timing and performance of their trades relative to market movements.

Question 6

How many companies is Ann Hanham associated with?

Accepted Answer

Ann Hanham has filed Form 4 transactions for 5 different companyies. Their primary association is with BIOMIMETIC THERAPEUTICS, INC. (BMTI), where they serve as Executive.

Question 7

How much BMTI stock does Ann Hanham own?

Accepted Answer

Ann Hanham currently owns 46,622 shares of BIOMIMETIC THERAPEUTICS, INC. (BMTI), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.

Question 8

What is Ann Hanham's equity in BIOMIMETIC THERAPEUTICS, INC.?

Accepted Answer

Ann Hanham's equity position in BIOMIMETIC THERAPEUTICS, INC. consists of 46,622 shares valued at approximately $0. As Executive, they have executed 49 insider transactions, with $15.4K in purchases and $5.4M in sales.

Question 9

Where can I find Ann Hanham's SEC Form 4 filings?

Accepted Answer

All of Ann Hanham's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Ann Hanham has 49 Form 4 filings on record as an insider at BIOMIMETIC THERAPEUTICS, INC..

Question 10

What is Ann Hanham's net worth from BMTI?

Accepted Answer

Based on their current BMTI stock holdings, Ann Hanham has equity worth approximately $0 in BIOMIMETIC THERAPEUTICS, INC.. This value is based on 46,622 shares at current market prices and does not represent their total net worth, which may include other assets and investments.

DATE	TICKER	VALUE	TYPE	SHARES	PRICE	10b5-1
Jun 20, 2024	SCYX	$0	Award	23,000	$N/A	Discretionary
Jun 15, 2023	SCYX	$0	Award	10,000

Ann Hanham

Position Evolution

Equity Curve

Trading Analytics

Recent Transactions

Largest Transactions

Companies Associated

Ann Hanham Trading Summary

How Much BMTI Stock Does Ann Hanham Own?

Is Ann Hanham Buying or Selling BMTI?

Ann Hanham's Recent Stock Transactions

Frequently Asked Questions

Track Ann Hanham's Trades